10.7
Nonsense-mediated mRNA Decay
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual…
When an mRNA molecule is transported from the nucleus to the cytosol, as its 5ʹ end emerges from a nuclear pore, a ribosome begins to translate it.
This test translation checks the mRNA for errors and flags irregularly processed mRNAs for degradation.
In this mRNA surveillance mechanism, called the nonsense-mediated mRNA decay pathway, or NMD, the ribosome can detect if an mRNA molecule has a nonsense or stop codon in the wrong place.
Generally, a pre-mRNA can contain stop codons within introns, in addition to the intended stop codon. When this pre-mRNA is spliced and processed in the nucleus, exon junction complexes, or EJCs, bind the mRNA at each splice site.
In the test round of translation, the EJCs are displaced by the moving ribosome.
In a normally spliced mRNA, the stop codon, marked by the sequence UAA, UAG or UGA, lies within the last exon. So, when the ribosome reaches it and the translation is terminated, there are no bound EJCs.
Such an mRNA passes the quality check and is now available for further rounds of translation.
Incompletely spliced mRNAs still have nonsense codons present in the reading frame of the mRNA. This phenomenon is observed more frequently in organisms with longer introns.
As a ribosome translates this mRNA, it reaches a stop codon, before interacting with the final EJC. The stalled ribosome terminates the translation prematurely while the pathway activates the NMD response.
The bound EJC serves as a binding platform for NMD factors including Up-frameshift proteins, Upf1, Upf2, and Upf3, and a phosphorylating enzyme SMG. These proteins recruit exonucleases that degrade the faulty mRNA.
NMD surveillance is critical in selecting for genetic combinations that can produce a functional protein.
View the full transcript and gain access to JoVE Core videos
Q1: What is nonsense-mediated mRNA decay and why does it occur?
Nonsense-mediated mRNA decay (NMD) is a cellular quality control mechanism that detects and degrades mRNAs containing premature termination codons (PTCs). These aberrant transcripts would otherwise produce truncated, potentially harmful proteins. NMD prevents the accumulation of defective proteins by recognizing specific markers during translation and targeting the faulty mRNA for destruction, protecting cellular function.
Q2: How does the ribosome recognize a premature termination codon during NMD?
During translation, the ribosome encounters a stop codon and recruits release factors to terminate protein synthesis. NMD distinguishes premature termination codons from normal ones by examining exon junction complexes (EJCs) positioned downstream of the stop codon. If an EJC remains more than 50-55 nucleotides downstream after termination, the ribosome signals that the stop codon is premature, triggering NMD pathway activation.
Q3: What role do exon junction complexes play in nonsense-mediated decay?
Exon junction complexes (EJCs) are protein assemblies deposited 20-24 nucleotides upstream of exon-exon junctions during pre-mRNA splicing. During normal translation, the ribosome displaces all EJCs as it moves along the mRNA. If a premature termination codon occurs before the ribosome can remove downstream EJCs, these complexes remain bound and recruit NMD factors, marking the transcript for degradation.
Q4: Which proteins are recruited to trigger mRNA degradation in the NMD pathway?
Key NMD factors include UPF1, UPF2, and UPF3, which form a complex at the termination site when downstream exon junction complexes are detected. These proteins interact with release factors and recruit additional degradation machinery. The UPF complex ultimately directs the mRNA toward decapping and deadenylation, leading to rapid 5' to 3' exonucleolytic degradation of the aberrant transcript.
Q5: How does nonsense-mediated decay differ from normal mRNA degradation?
NMD is a selective, rapid surveillance mechanism triggered specifically by premature termination codons and downstream exon junction complexes, whereas normal mRNA degradation follows programmed decay pathways based on mRNA age and sequence elements. NMD acts during translation to eliminate defective transcripts before they produce harmful proteins, providing an immediate quality control response distinct from constitutive mRNA turnover.
Q6: What happens to proteins produced from mRNAs that escape nonsense-mediated decay?
If an mRNA with a premature termination codon escapes NMD detection, the ribosome produces a truncated protein lacking its C-terminal domain. These incomplete proteins often misfold and become unstable. Such defective proteins are typically recognized as misfolded and targeted for regulated and targeted protein degradation through cellular quality control systems, preventing their accumulation.
Q7: Can nonsense-mediated decay affect normal gene expression or only aberrant transcripts?
NMD primarily targets aberrant mRNAs containing premature termination codons, but some normal transcripts are also regulated by NMD. Certain genes naturally produce mRNAs with upstream open reading frames or introns in their 3' untranslated regions that trigger NMD, allowing cells to fine-tune expression of specific genes through this surveillance pathway.